Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)

South Korea · Delayed Price · Currency is KRW

6,290.00

-10.00 (-0.16%)

At close: Jun 16, 2026

9.58% (1Y)

Market Cap	230.59B +8.9%
Revenue (ttm)	1.69T +5.4%
Net Income	21.62B -16.9%
EPS	504.35 -22.7%
Shares Out	36.66M
PE Ratio	12.47
Forward PE	n/a
Dividend	100.00 (1.59%)
Ex-Dividend Date	Mar 31, 2026

Volume	127,546
Open	6,360.00
Previous Close	6,300.00
Day's Range	6,260.00 - 6,490.00
52-Week Range	5,500.00 - 12,800.00
Beta	0.34
Analysts	Buy
Price Target	15,000.00 (+138.47%)
Earnings Date	Aug 14, 2026

About Kwang Dong Pharmaceutical

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti-inflammatory agents, neuropsychiatric solvent, digestive organ agent, antibiotic, and vitamins. The company also offers supplements for low content vi... [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 1963

Employees 1,021

Stock Exchange Korea Stock Exchange

Ticker Symbol 009290

Full Company Profile

Financial Performance

In 2025, Kwang Dong Pharmaceutical's revenue was 1.66 trillion, an increase of 1.15% compared to the previous year's 1.64 trillion. Earnings were 20.97 billion, a decrease of -48.20%.

Financial Statements